Influenza vaccination and Guillain-Barré syndrome.
Institute for Clinical Evaluative Sciences, Toronto, ON M4N 3M5, Canada; Department of Family and Community Medicine, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada. Electronic address: jeff.kwong@utoronto.ca.
Jeffrey C
JC
Kwong
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada.
Natasha S
NS
Crowcroft
Institute for Clinical Evaluative Sciences, Toronto, ON M4N 3M5, Canada; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada; Department of Epidemiology & Community Medicine, University of Ottawa, Ottawa, ON, Canada.
Kumanan
K
Wilson
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Allison J
AJ
McGeer
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada.
Shelley L
SL
Deeks
D005260:Female; D020275:Guillain-Barre Syndrome / Q000139:chemically induced*; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D014611:Vaccination / Q000009:adverse effects*
D007252:Influenza Vaccines